Literature DB >> 7270091

The acute effect of metoclopramide on plasma prolactin during pregnancy.

J M Brandes, J Itskovitz, M Fisher, Z Shen-Orr, D Barzilai.   

Abstract

The effect of metoclopramide on plasma prolactin levels was studied in 10 women in the second half of pregnancy. The IV injection of 10 mg metoclopramide produces a significant rise in prolactin in 15 minutes, a peak of up to 6.5-fold over basal levels at 30 minutes and a sustained significant elevation for at least 4 hours. The results of this study indicate that maternal plasma protein levels although elevated, are still under inhibitory control and that the prolactin releasing capacity of the pituitary is maintained during pregnancy. The elevated hyperprolactinemia induced by metoclopramide may be of help in investigating the role of prolactin in human pregnancy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7270091     DOI: 10.3109/00016348109158125

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  4 in total

1.  Maternal serum hormone changes during abortion induced with 9-deoxo-16, 16-dimethyl-9-methylene prostaglandin E2.

Authors:  K Bremme; P Eneroth; M Bygdeman
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

2.  Effect of metoclopramide on maternal and fetal hyperprolactinemia.

Authors:  G Robuschi; R Emanuele; L d'Amato; M Salvi; E Dall'Aglio; E Gardini; M Fatone; S Foscolo; A Gnudi; E Roti
Journal:  J Endocrinol Invest       Date:  1983-04       Impact factor: 4.256

Review 3.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

4.  Effect of cimetidine on maternal and fetal prolactin secretion during labor.

Authors:  I E Messinis; N Tsirkas; K Diamantis; S Vasakos; O Tsolas; D Lolis
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.